Project Grant HT9425261E411
Award Date 9/1/26
Completion Date 8/31/30
Dollars Obligated $3.5M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Leipsic, DE 19901, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...
- Federal Grant Award Summary 149 Bio LLC received a $5.1M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2029. The award supports the development of a myeloid-targeted novel therapeutic intervention for glomerular diseases. This research initiative will be conducted at the awardee's facility in Miami, FL and aims to advance biomedical solutions relevant to military health...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $997,343 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year period beginning September 1, 2025, and concluding August 31, 2028. The award supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis, representing a translational research initiative aligned with the DHA's mission to advance innovative...
- Federal Grant Award Summary New York University School of Medicine received a $1.0 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2029. The award supports research on diffusion magnetic resonance imaging (MRI) biomarkers of axonal degeneration in amyotrophic lateral sclerosis (ALS). The research will be conducted at NYU's facility in New York, NY, and is expected to...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2028. This award supports the development and validation of cell-free deoxyribonucleic acid (DNA) epigenetic biomarkers for multiple sclerosis, a three-year research initiative conducted at UCSF's San Francisco facility. The project...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $320,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The award supports research investigating the impact of the integrated stress response on visual synaptic circuits in multiple sclerosis (MS). This research endeavor will be conducted at the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $1.23M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2028. The award supports biomarker development research focused on refining an individualized risk-adapted approach to bladder-sparing treatment for muscle-invasive bladder cancer. This research initiative aims to advance clinical decision-making and...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $507,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research to investigate tumor-intrinsic epigenetic mechanisms that modulate antitumor immune responses in metastatic prostate cancer. This research initiative advances the DHA's mission to transform healthcare...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai (ISMMS) received a $505,270 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with a completion date of September 29, 2027. The award supports research investigating the impact of reprogrammed PIK3R1-insulin-glucose metabolism pathway in lethal prostate cancer to develop therapeutic strategy. This research aligns with the...
- Federal Project Grant Summary Memsel Inc. received a $4.52M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 1, 2025, with a completion date of August 31, 2027. The grant supports the development of advanced wound care solutions specifically designed to address multi-drug resistant infections and hemorrhage control in battlefield conditions. The research and development effort will leverage Memsel...